Syngene Board Meeting Scheduled to Approve Quarterly Results

Syngene International has announced a board meeting scheduled for November 05, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ending September 30, 2025 (Q2). The trading window for company insiders has been closed from October 01, 2025, and will remain closed until 48 hours after the declaration of the financial results.

Board Meeting Announcement

Syngene International will hold a board meeting on November 05, 2025. The primary agenda is to review and approve the unaudited financial results. These results will cover both standalone and consolidated figures.

Financial Results Under Review

The board will specifically focus on the financial performance for the quarter and half-year period that ended on September 30, 2025, corresponding to Q2 of the financial year.

Trading Window Closure

In accordance with regulations, the trading window for company insiders has been closed since October 01, 2025. It will re-open 48 hours after the official release of the financial results on November 05, 2025. This restriction applies to all individuals with access to unpublished price-sensitive information.

Conference Call for Analysts

The company will host a conference call for analysts and investors on November 06, 2025. More information regarding the conference call, including dial-in details and presentation materials, will be made available on the company’s website.

Source: BSE

InvestyWise News
InvestyWise News
Covers market-moving news with speed and precision, delivering sharp insights to help readers stay ahead in the fast-paced world of stocks.

Latest articles

Related articles

Leave a reply

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!